2014
Assessing the benefits and risks of tight glycemic control in critically ill children
Kandil S, Faustino E. Assessing the benefits and risks of tight glycemic control in critically ill children. Pediatric Health Medicine And Therapeutics 2014, 5: 93-98. DOI: 10.2147/phmt.s50410.Peer-Reviewed Original ResearchTight glycemic controlIntensive care unitIll childrenGlycemic controlCare unitSurgical intensive care unitSubsequent multicenter trialSingle-center trialInsulin-induced hypoglycemiaIntravenous insulinCenter trialIll adultsIll patientsMulticenter trialTrialsHypoglycemiaChildrenHigh rateMortalityCurrent literatureInsulinRiskHyperglycemiaPatients
2013
Prevalence and characteristics of prematurely terminated cancer clinical trials.
Stensland K, Latif A, Hendricks R, Roper N, McBride R, Hall S, Oh W, Galsky M. Prevalence and characteristics of prematurely terminated cancer clinical trials. Journal Of Clinical Oncology 2013, 31: 6613-6613. DOI: 10.1200/jco.2013.31.15_suppl.6613.Peer-Reviewed Original Research
2004
Use of Presumptive Antibiotics following Tube Thoracostomy for Traumatic Hemopneumothorax in the Prevention of Empyema and Pneumonia—A Multi-Center Trial
Maxwell RA, Campbell DJ, Fabian TC, Croce MA, Luchette FA, Kerwin AJ, Davis KA, Nagy K, Tisherman S. Use of Presumptive Antibiotics following Tube Thoracostomy for Traumatic Hemopneumothorax in the Prevention of Empyema and Pneumonia—A Multi-Center Trial. Journal Of Trauma And Acute Care Surgery 2004, 57: 742-749. PMID: 15514527, DOI: 10.1097/01.ta.0000147481.42186.42.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAntibiotic ProphylaxisCefazolinChest TubesDevice RemovalDouble-Blind MethodEmpyema, PleuralFemaleFollow-Up StudiesHemopneumothoraxHumansInjury Severity ScoreLogistic ModelsMaleMiddle AgedMultivariate AnalysisPneumonia, BacterialProspective StudiesReference ValuesRisk AssessmentThoracic InjuriesThoracostomyTrauma CentersTreatment OutcomeConceptsIncidence of empyemaRisk of empyemaPresumptive antibioticsTube thoracostomyTraumatic hemopneumothoraxDouble-blind trialUse of cefazolinLogistic regression analysisTube thoracostomy placementCenter trialTube placementInjury scoreAntibiotic useGroup A.EmpyemaThoracostomy placementChi analysisPneumoniaThoracostomyHemopneumothoraxPatientsRegression analysisAntibioticsInjuryIncidence
2001
Clinical studies of angiogenesis inhibitors: The university of texas md anderson center trial of human endostatin
Herbst R, Lee A, Tran H, Abbruzzese J. Clinical studies of angiogenesis inhibitors: The university of texas md anderson center trial of human endostatin. Current Oncology Reports 2001, 3: 131-140. PMID: 11177745, DOI: 10.1007/s11912-001-0013-8.Peer-Reviewed Original ResearchConceptsPhase I trialI trialClinical studiesHuman endostatinTumor vasculatureSolid tumor malignanciesAnti-angiogenic agentsAnti-angiogenic mechanismAnti-angiogenic compoundsToxic cancer treatmentsAdvanced diseaseBlood vessel supplyCenter trialMinimal diseaseTumor sizeNovel agentsSurrogate endpointsNew agentsSide effectsBiologic mechanismsSingle agentAngiogenesis inhibitorsGrowth-inhibiting moleculesNon-toxic agentsTumor growth
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply